Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

Progress towards an HIV cure

News
25 November 2013
New & experimental HIV treatments

Gilead's Vitekta Gets Approval in European Union

Editor's pick
Wall Street Journal
19 November 2013
New & experimental HIV treatments

Once-daily raltegravir effective as maintenance therapy

News
31 October 2013
Treatment guidelines

Recommendation on Integrase Inhibitor Use in Antiretroviral Treatment-Naive HIV-Infected Individuals from the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents

Editor's pick
AIDS Info
31 October 2013
New & experimental HIV treatments

Dolutegravir matches or surpasses other regimens for first-line HIV treatment

News
30 October 2013
New & experimental HIV treatments

Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia

Editor's pick
Sangamo press release
29 October 2013
New & experimental HIV treatments

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine

Editor's pick
Viiv Healthcare
23 October 2013
New & experimental HIV treatments

Future HIV care will include both novel antiretroviral drugs and new treatment strategies

News
22 October 2013
New & experimental HIV treatments

GSK1265744 rapidly suppresses HIV and appears safe at selected dose

News
20 October 2013
New & experimental HIV treatments

HIV Dual Therapy Matches Standard Triple Cocktail

Editor's pick
MedPage Today
19 October 2013
New & experimental HIV treatments

CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts

News
18 October 2013
New & experimental HIV treatments

MODERN Study Stopped: An NRTI-Sparing, Two-Drug Initial Regimen Disappoints Again

Editor's pick
NEJM Journal Watch
17 October 2013
The search for a cure

Elusive secret of HIV long-term immunity

Editor's pick
EurekAlert!
17 October 2013
Drug interactions & pharmacokinetics

Merck plans phase III study of once-daily raltegravir (Isentress)

Editor's pick
Merck press release
16 October 2013
New & experimental HIV treatments

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Editor's pick
News Medical Net
15 October 2013
New & experimental HIV treatments

Viriom Reports Clinical Efficacy Data for VM-1500, a New HIV NNRTI

Editor's pick
Marketwired (press release)
8 October 2013
The search for a cure

Gladstone lab uncovers a potential HIV cure — and it's already a drug

Editor's pick
San Francisco Business Times
6 October 2013
PrEP

Long-Acting HIV Antiretrovirals May Be Revolutionary. But Will They Be Worth It?

Editor's pick
The Body Pro
6 October 2013
Injectable & long-acting HIV treatment

Long-acting antiretrovirals may improve survival for people with poor adherence

News
4 October 2013
PrEP science

New integrase inhibitor GSK1265744 safe and well tolerated in eight studies

News
4 October 2013
New & experimental HIV treatments

From sky high to CHAI – what needs to be done about dolutegravir pricing?

Editor's pick
HIV I-Base
2 October 2013
New & experimental HIV treatments

Stribild is effective and well tolerated in older people with HIV

News
2 October 2013
New & experimental HIV treatments

European Commission Approves Gilead Sciences' Tybost(TM), a New Boosting Agent for HIV Therapy

Editor's pick
Gilead press release
26 September 2013
Adherence

Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation

News
26 September 2013